Bridgeway Capital Management’s Vascular Solutions VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-8,500
Closed -$477K – 1534
2016
Q4
$477K Buy
+8,500
New +$433K 0.01% 1106
2015
Q1
– Sell
-32,700
Closed -$888K – 1546
2014
Q4
$888K Hold
32,700
– – 0.02% 815
2014
Q3
$808K Sell
32,700
-24,350
-43% -$578K 0.02% 843
2014
Q2
$1.27M Hold
57,050
– – 0.03% 679
2014
Q1
$1.49M Buy
57,050
+250
+0.4% +$6.22K 0.04% 600
2013
Q4
$1.32M Hold
56,800
– – 0.04% 642
2013
Q3
$954K Hold
56,800
– – 0.03% 744
2013
Q2
$836K Buy
+56,800
New +$893K 0.03% 706

Other funds holding VASC

Bridgeway Capital Management's VASC Position: Q1 2017 in Review

Bridgeway Capital Management sold out of Vascular Solutions (VASC) in Q1 2017, closing a stake of 8,500 shares — an estimated $477K sold.

Bridgeway Capital Management first reported a position in VASC in Q2 2013 and held it in 8 quarters. The position peaked at $1.49M in Q1 2014. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Bridgeway Capital Management reported no remaining Vascular Solutions position as of Q1 2017 after selling out during the quarter.
  • Bridgeway Capital Management sold 8,500 Vascular Solutions shares in Q1 2017, an estimated $477K.
  • Bridgeway Capital Management first reported a position in Vascular Solutions in Q2 2013 and held it in 8 quarters.
  • Bridgeway Capital Management's Vascular Solutions position peaked at $1.49M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions as of Q1 2017.

Based on Bridgeway Capital Management's 13F filing for Q1 2017, filed 15 May 2017.